Breaking News
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
September 24, 2018 - How a virus destabilizes the genome
September 24, 2018 - Old letters provide insight into Spanish flu pandemic horror
September 23, 2018 - Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain
September 23, 2018 - New research hub to drive radical change in development and manufacturing of vaccines
September 23, 2018 - AHA: For Hispanics, Neighborhood May Be Key Factor in Heart Disease Risk
September 23, 2018 - Excessive airway nerves tied to more severe asthma symptoms, study finds
September 23, 2018 - Study highlights need to remain vigilant in maintaining key infection control processes
September 23, 2018 - Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy
September 23, 2018 - New naturally occurring antibiotic found effective against Mycobacterium tuberculosis
September 23, 2018 - First-in-human phase 0 study shows clinically-relevant activity of new drug in glioblastoma
September 23, 2018 - Removing tobacco product display from shops reduced number of children buying cigarettes
September 23, 2018 - Random fraction of specialized immune cells leads the charge in battling invaders
September 23, 2018 - Few minutes of sprinting exercise may be as effective as longer exercise sessions
September 23, 2018 - Researchers use neutrons to make first direct observations of water in lipid bilayers
September 23, 2018 - Researchers demonstrate pre-clinical success for universal flu vaccine in new paper
September 23, 2018 - Study reveals surprising gaps in some HIV medical providers’ knowledge of ACA
September 23, 2018 - Oxehealth secures European medical device accreditation for vital signs measurement software
September 23, 2018 - HTN Tx Intensification Common Upon Discharge in U.S. Vets
September 23, 2018 - Fibre can strengthen the intestinal barrier
September 23, 2018 - New platform examines infectious pathogens that may spread from animals to humans
September 23, 2018 - Demographers create detailed color map of population aging in Europe
September 23, 2018 - New type of fatty acid can slow down overreactive immune system
September 23, 2018 - Innovative procedure could provide breakthrough in treating early-stage lung cancer
September 23, 2018 - Research finds drop in number of measles cases in the EU/EEA since March 2018
September 23, 2018 - Researchers acquire new insights into DNA polymerases
September 23, 2018 - Alzheimer’s diagnosis might become simpler with new brain imaging method
September 23, 2018 - Reports Warn of Growing Opioid Crisis Among Seniors
September 23, 2018 - Researchers unravel why people with HIV suffer from more neurologic diseases
September 23, 2018 - Human brain structured to make best possible decision with limited resources
September 23, 2018 - KHN’s ‘What the Health?’ Health on the hill
September 23, 2018 - Bad air and inadequate data prove an unhealthy mix
September 23, 2018 - Regular bedtime and wake time important for heart, metabolic health even among adults
September 23, 2018 - HIV and a tale of a few cities
September 23, 2018 - NIH launches clinical trial to test infusions of combination antibodies in people with HIV
September 23, 2018 - Researchers develop new system to detect consumption of synthetic cannabinoids
September 23, 2018 - Vax-Hub to influenze radical change in development and manufacturing of vaccines
September 23, 2018 - People who have slept lesser than seven hours have higher risks of car crashes
September 23, 2018 - an ancient art may work best to prevent falls in old age
September 23, 2018 - Consumption of foods with lower nutritional quality related to increased cancer risk
September 23, 2018 - Patient Health Information Often Shared Electronically
September 23, 2018 - Can machine learning bring more humanity to health care?
September 23, 2018 - Body organs undergo structural changes in response to diet
September 23, 2018 - Genetic polymorphisms linked with muscle injury and stiffness
September 23, 2018 - As states try to rein in drug spending, feds slap down one bold Medicaid move
September 22, 2018 - Why Eczema Is Tougher to Treat for Black Patients
September 22, 2018 - Team reveals that human genome could contain up to 20 percent fewer genes
September 22, 2018 - USC research uncovers previously unknown genetic risk factor for Alzheimer’s disease
September 22, 2018 - Novel method achieves accurate and precise temperature estimation in fat-containing tissues
September 22, 2018 - BSI accredits Oxehealth’s vital signs measurement software as Class IIa medical device
September 22, 2018 - Evolution of psychiatric disorders and human personality traits
September 22, 2018 - Obesity in early puberty doubles asthma risk for boy’s future offspring
September 22, 2018 - World’s most advanced real-time patient monitoring platform receives key US patent
September 22, 2018 - Study explores connection between sexuality and cognitive status in older adults
September 22, 2018 - LSTM partners with TB Alliance to develop novel TB drug regimens
September 22, 2018 - Annual wellness visits improve delivery of preventive services in elderly population
September 22, 2018 - CHMP provides positive opinion to Cabometyx for previously-treated patients with hepatocellular carcinoma
September 22, 2018 - Hispanic communities with high proportions of Hispanics face more cardiovascular-related death
September 22, 2018 - Vici syndrome – Genetics Home Reference
September 22, 2018 - Single-dose drug can shorten flu symptoms by about a day, studies suggest
September 22, 2018 - AMSBIO launches circulating tumor DNA Reference Standards
September 22, 2018 - Sandalwood mimicking odorant could stimulate hair growth in humans
September 22, 2018 - Overlooked immune cells could play a key role in cancer immunotherapy, claims new study
September 22, 2018 - Study reveals prevalence of diagnosed type 1 and type 2 diabetes among American adults
September 22, 2018 - Researchers develop fast detection strategy to know type of virus acquired by patients
September 22, 2018 - Global Prevalence of Insufficient Activity 27.5 Percent
September 22, 2018 - Strategies to protect bone health in hematologic stem cell transplant recipients
September 22, 2018 - Brigham Genomic Medicine program unravels 30 medical mysteries
September 22, 2018 - New system harnesses power of bubbles to destroy dangerous biofilms
September 22, 2018 - Inflammation plays crucial role in preventing heart attacks and strokes, study reveals
Team explores diabetes drug’s ability to treat RSV infection

Team explores diabetes drug’s ability to treat RSV infection

image_pdfDownload PDFimage_print
Team explores diabetes drug’s ability to treat RSV infection
The team studying a diabetes drug’s ability to treat RSV includes, from left, Kevin Niswender, MD, PhD, R. Stokes Peebles, MD, Tina Hartert, MD, MPH, Lisa Bastarache, MS, and Melissa Bloodworth, PhD. Credit: Joe Howell

A drug used to treat diabetes may point to new therapies for respiratory syncytial virus (RSV) bronchiolitis—inflammation and obstruction of the lungs’ small airways. A multi-disciplinary team of Vanderbilt investigators has demonstrated that liraglutide reduces the inflammatory response to RSV infection in a mouse model of the disease.

The findings were reported in the Journal of Allergy and Clinical Immunology.

Liraglutide is one of six “GLP-1R agonists” approved to treat type 2 diabetes. These drugs enhance insulin secretion from the pancreas by activating the glucagon-like peptide 1 receptor (GLP-1R).

“The connection between GLP-1R signaling and lung inflammation was a surprise,” said R. Stokes Peebles, MD, Elizabeth and John Murray Professor of Medicine. His team was exploring a suggestion from a friend and colleague who studies diabetes and obesity, Kevin Niswender, MD, Ph.D., associate professor of Medicine.

The two have co-coached their daughters’ basketball teams for the past several years.

“One day after practice, Kevin said, ‘you need to look at these drugs in your models,'” Peebles said.

Niswender explained that GLP-1R agonists have anti-inflammatory properties, but the drugs hadn’t been examined in the type of allergy and virally mediated airway inflammation that Peebles and his team study.

“We’ll almost always try out a new idea because you never know what might hit,” Peebles said.

Melissa Bloodworth, Ph.D., a student in the MD/Ph.D. program, infected mice with a strain of RSV that had been isolated from an infant who was hospitalized with severe lower respiratory tract infection and bronchiolitis. The RSV strain induced high levels of inflammatory factors and airway mucus in mice, conditions that mimicked severe infection in patients.

Treatment of the mice with liraglutide, before or after RSV infection, decreased production of inflammatory factors in the lungs and reduced inflammation, airway responsiveness and airway mucus.

“This drug worked really well to decrease the pathology that occurs in the lungs, suggesting its potential for treating severe RSV infection,” Peebles said.

RSV bronchiolitis is the No. 1 cause of hospitalization for infants in the United States, with up to 125,000 children hospitalized each year, according to the National Institute of Allergy and Infectious Diseases. Adults older than 65 are also vulnerable to lung disease from severe RSV infection.

Infants and children at high risk for RSV bronchiolitis can receive the drug palivizumab to prevent RSV infection, but there are no treatment options after RSV infection occurs.

“A vast number of children who don’t have any risk factors get RSV bronchiolitis and are hospitalized, and they are the patients that a drug like liraglutide potentially could help,” Peebles said.

Niswender is working with medicinal chemists at Vanderbilt to develop more effective GLP-1R agonists that can be targeted specifically to the lungs via inhalation.

Bloodworth also measured the antiviral immune response in mice infected with RSV and treated with liraglutide.

She found no difference in mediators of the antiviral immune response, including interferon-gamma and certain white blood cells (Th1 T helper cells and natural killer cells).

“This was important because we wouldn’t want to pursue a treatment for RSV that has a negative effect on the antiviral immune response,” Bloodworth said.

Bloodworth also found that liraglutide treatment of a first RSV infection did not block a protective immune response to a second RSV infection in mice.

To search for a connection between GLP-1R signaling and human RSV disease, the researchers conducted a Phenome-Wide Association Study (PheWAS) with Lisa Bastarache, MS, lead data scientist in the Center for Precision Medicine. PheWAS searches for associations between known genetic variants and phenotypes (such as diagnoses) in the medical record.

Using existing databases, the investigators identified a genetic variant associated with a lower response to GLP-1. Then they conducted a PheWAS for that variant in Vanderbilt’s BioVU biobank. They found that the gene variant was associated with acute bronchiolitis.

“The fact that we found an association between GLP-1R signaling and human bronchiolitis corroborates our mouse studies and is very exciting,” Bloodworth said.

The studies have opened an entirely new area of research, Peebles said.

“The GLP-1 receptor is highly expressed in the lung, but no one knows what it’s doing,” he said. “We’re working on understanding the role of endogenous GLP-1 receptor signaling in the lungs—what happens if the receptor is missing and what happens in the setting of allergic and viral inflammation.”

Peebles and his colleagues are also exploring the use of GLP-1R agonists in people who have obesity and asthma.

“There’s an epidemic of asthma in people who are obese, and we’re interested in these drugs as a potential therapy for both obesity and asthma related to obesity,” he said.

The RSV strain used in the mouse model was isolated from an infant enrolled in a study of RSV and asthma directed by Tina Hartert, MD, MPH, Lulu H. Owen Professor of Medicine, and supported by an Asthma and Allergic Diseases Cooperative Research Center grant. Martin Moore, Ph.D., at Emory University, isolated and grew the viruses.


Explore further:
Two novel immune-response clusters identified to RSV

More information:
Melissa H. Bloodworth et al. Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus–induced type 2 responses and immunopathology, Journal of Allergy and Clinical Immunology (2018). DOI: 10.1016/j.jaci.2018.01.053

Journal reference:
Journal of Allergy and Clinical Immunology

Provided by:
Vanderbilt University

Tagged with:

About author

Related Articles